abstract |
The present invention relates to compounds of formula I, wherein R1, R2, R3, R4, X and Y have the meanings indicated in the specification. [Chemical 1] These compounds have an immunomodulatory effect and an inhibitory effect on the release of IL-1β and TNF-α. They can therefore be used to treat illnesses associated with immune system disorders. |